Loading...
Loading...
Of the 12 tracked institutions holding ABUS, 5 have a 3-year clone track record — 5 of them beat the S&P. Average holder's clone alpha: +3.5pt. It's a gauge of who owns the name, not just how many.
Among the 12 tracked institutional investors we monitor, ABUS (ARBUTUS BIOPHARMA CORP) is held with a combined value of $152.89M across 33,338,116 shares. The largest holder is BlackRock, Inc. with a position worth $58.35M. 3 funds opened new positions in the most recent quarter. 6 funds increased their holdings. 3 funds reduced their position.
Total Institutional Value
$152.89M
Total Shares Held
33,338,116
Institutional Holders
12
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $58.35M | 0.00% | -0.7% |
| 2 | VANGUARD GROUP INC | $44.46M | 0.00% | +2.8% |
| 3 | STATE STREET CORP | $28.54M | 0.00% | +7.4% |
| 4 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $11.99M | 0.02% | -38.6% |
| 5 | CITADEL ADVISORS LLC | $3.05M | 0.00% | +545.9% |
| 6 | MILLENNIUM MANAGEMENT LLC | $2.89M | 0.00% | New |
| 7 | WELLINGTON MANAGEMENT GROUP LLP | $1.98M | 0.00% | -7.0% |
| 8 | FMR LLC | $653.07K | 0.00% | +6.3% |
| 9 | PRICE T ROWE ASSOCIATES INC /MD/ | $522.00K | 0.00% | +30.0% |
| 10 | Magnetar Financial LLC | $263.32K | 0.00% | New |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of ABUS with a position worth $58.35M, representing 0.00% of their portfolio. In total, 12 institutional investors hold ABUS with a combined value of $152.89M.
In the most recent quarter, 3 funds opened a new position in ABUS. Additionally, 6 increased their holdings and 3 reduced their positions.
Institutional investors hold $152.89M worth of ABUS stock across 12 positions. The largest institutional holder is BlackRock, Inc. with $58.35M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ABUS, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their ABUS positions.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
Last Close
$4.38
2026-07-24
YTD
-8.2%
60% of 52-week range
